Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Ilona J.M. den Hartog et al.|Clinical Cancer Research|2015Cited by 69
HG-67PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPGDiana Carvalho, Chris Jones, Kathryn R. Taylor et al.|Neuro-Oncology|2016Cited by 1
Supplementary Materials and Methods from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0
Supplementary figures S1-8 from Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaM. Emmy M. Dolman, Jan J. Molenaar, Evon Poon et al.|Unknown|2023Cited by 0